These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 22726608)
1. The pros and cons of chemokines in tumor immunology. Viola A; Sarukhan A; Bronte V; Molon B Trends Immunol; 2012 Oct; 33(10):496-504. PubMed ID: 22726608 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory chemokines and metastasis--tracing the accessory. Borsig L; Wolf MJ; Roblek M; Lorentzen A; Heikenwalder M Oncogene; 2014 Jun; 33(25):3217-24. PubMed ID: 23851506 [TBL] [Abstract][Full Text] [Related]
3. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. Mishra P; Banerjee D; Ben-Baruch A J Leukoc Biol; 2011 Jan; 89(1):31-9. PubMed ID: 20628066 [TBL] [Abstract][Full Text] [Related]
4. The role of chemokines in cancer immune surveillance by the adaptive immune system. Krieg C; Boyman O Semin Cancer Biol; 2009 Apr; 19(2):76-83. PubMed ID: 19038343 [TBL] [Abstract][Full Text] [Related]
5. The chemokine network: a target in cancer biology? Slettenaar VI; Wilson JL Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642 [TBL] [Abstract][Full Text] [Related]
6. The multifaceted roles of chemokines in malignancy. Ben-Baruch A Cancer Metastasis Rev; 2006 Sep; 25(3):357-71. PubMed ID: 17016763 [TBL] [Abstract][Full Text] [Related]
7. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW; Baseman A; Assikis V; Zhau HE J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017 [TBL] [Abstract][Full Text] [Related]
8. Inflammation and immunity in the tumor environment. Maletzki C; Emmrich J Dig Dis; 2010; 28(4-5):574-8. PubMed ID: 21088404 [TBL] [Abstract][Full Text] [Related]
9. New insights into chronic inflammation-induced immunosuppression. Kanterman J; Sade-Feldman M; Baniyash M Semin Cancer Biol; 2012 Aug; 22(4):307-18. PubMed ID: 22387003 [TBL] [Abstract][Full Text] [Related]
10. [Role of chemokines in melanoma progression]. Monteagudo C; Pellín-Carcelén A; Martín JM; Ramos D Actas Dermosifiliogr; 2011 Sep; 102(7):498-504. PubMed ID: 21531362 [TBL] [Abstract][Full Text] [Related]
12. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. O'Hayre M; Salanga CL; Handel TM; Allen SJ Biochem J; 2008 Feb; 409(3):635-49. PubMed ID: 18177271 [TBL] [Abstract][Full Text] [Related]
13. Chemokines in cancer. Chow MT; Luster AD Cancer Immunol Res; 2014 Dec; 2(12):1125-31. PubMed ID: 25480554 [TBL] [Abstract][Full Text] [Related]
16. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Filipazzi P; Bürdek M; Villa A; Rivoltini L; Huber V Semin Cancer Biol; 2012 Aug; 22(4):342-9. PubMed ID: 22369922 [TBL] [Abstract][Full Text] [Related]
17. Melanoma-induced immunosuppression and its neutralization. Umansky V; Sevko A Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515 [TBL] [Abstract][Full Text] [Related]
18. Tumor-associated neutrophils: new targets for cancer therapy. Gregory AD; Houghton AM Cancer Res; 2011 Apr; 71(7):2411-6. PubMed ID: 21427354 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory chemokines in cancer growth and progression. Rollins BJ Eur J Cancer; 2006 Apr; 42(6):760-7. PubMed ID: 16510278 [TBL] [Abstract][Full Text] [Related]
20. Mast cell: insight into remodeling a tumor microenvironment. Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]